View in EDS PDF Full Text

TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck.

Saved in:
Bibliographic Details
Title: TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck.
Authors: Rubió-Casadevall J; Medical Oncology Department, Institut Català d'Oncologia Girona, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Cirauqui Cirauqui B; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain., Martinez Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Plana Serrahima M; Medical Oncology Department, Institut Català d'Oncologia (ICO-Hospitalet), IDIBELL, Hospitalet de Llobregat, Llobregat, Spain., García Castaño A; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Carral Maseda A; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Iglesias Docampo L; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Pérez Segura P; Medical Oncology Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Ceballos Lenza I; Medical Oncology Department, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain., Gutiérrez Calderón V; UGCI Oncol. Hospital Universitario Regional y Virgen Victoria, IBIMA, Málaga, Spain., Fuster Salvà J; Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Pena Álvarez C; Medical Oncology Department, Centro Oncológico Galicia, A Coruña, Spain., Hernandez I; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Del Barco Morillo E; Medical Oncology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain., Chaves Conde M; Medical Oncology Department, Hospital Universitario Virgen de Valme, Sevilla, Spain., Martínez Galán J; Medical Oncology Department, Hospital Universitario Virgen Nieves, Instituto de Investigación Biosanitaria ibs, Granada, Spain., Durán Sánchez M; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain., Quiroga V; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain., Ortega E; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Mesia R; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain.; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain.
Source: Frontiers in oncology [Front Oncol] 2023 Aug 01; Vol. 13, pp. 1226939. Date of Electronic Publication: 2023 Aug 01 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37601652
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rubió-Casadevall+J%22">Rubió-Casadevall J</searchLink>; Medical Oncology Department, Institut Català d'Oncologia Girona, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.<br /><searchLink fieldCode="AU" term="%22Cirauqui+Cirauqui+B%22">Cirauqui Cirauqui B</searchLink>; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez+Trufero+J%22">Martinez Trufero J</searchLink>; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.<br /><searchLink fieldCode="AU" term="%22Plana+Serrahima+M%22">Plana Serrahima M</searchLink>; Medical Oncology Department, Institut Català d'Oncologia (ICO-Hospitalet), IDIBELL, Hospitalet de Llobregat, Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22García+Castaño+A%22">García Castaño A</searchLink>; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.<br /><searchLink fieldCode="AU" term="%22Carral+Maseda+A%22">Carral Maseda A</searchLink>; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.<br /><searchLink fieldCode="AU" term="%22Iglesias+Docampo+L%22">Iglesias Docampo L</searchLink>; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez+Segura+P%22">Pérez Segura P</searchLink>; Medical Oncology Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ceballos+Lenza+I%22">Ceballos Lenza I</searchLink>; Medical Oncology Department, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain.<br /><searchLink fieldCode="AU" term="%22Gutiérrez+Calderón+V%22">Gutiérrez Calderón V</searchLink>; UGCI Oncol. Hospital Universitario Regional y Virgen Victoria, IBIMA, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22Fuster+Salvà+J%22">Fuster Salvà J</searchLink>; Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain.<br /><searchLink fieldCode="AU" term="%22Pena+Álvarez+C%22">Pena Álvarez C</searchLink>; Medical Oncology Department, Centro Oncológico Galicia, A Coruña, Spain.<br /><searchLink fieldCode="AU" term="%22Hernandez+I%22">Hernandez I</searchLink>; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Del+Barco+Morillo+E%22">Del Barco Morillo E</searchLink>; Medical Oncology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Chaves+Conde+M%22">Chaves Conde M</searchLink>; Medical Oncology Department, Hospital Universitario Virgen de Valme, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez+Galán+J%22">Martínez Galán J</searchLink>; Medical Oncology Department, Hospital Universitario Virgen Nieves, Instituto de Investigación Biosanitaria ibs, Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Durán+Sánchez+M%22">Durán Sánchez M</searchLink>; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Quiroga+V%22">Quiroga V</searchLink>; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Ortega+E%22">Ortega E</searchLink>; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.<br /><searchLink fieldCode="AU" term="%22Mesia+R%22">Mesia R</searchLink>; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain.; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2023 Aug 01; Vol. 13, pp. 1226939. <i>Date of Electronic Publication: </i>2023 Aug 01 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37601652
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2023.1226939
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1226939
    Titles:
      – TitleFull: TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rubió-Casadevall J
      – PersonEntity:
          Name:
            NameFull: Cirauqui Cirauqui B
      – PersonEntity:
          Name:
            NameFull: Martinez Trufero J
      – PersonEntity:
          Name:
            NameFull: Plana Serrahima M
      – PersonEntity:
          Name:
            NameFull: García Castaño A
      – PersonEntity:
          Name:
            NameFull: Carral Maseda A
      – PersonEntity:
          Name:
            NameFull: Iglesias Docampo L
      – PersonEntity:
          Name:
            NameFull: Pérez Segura P
      – PersonEntity:
          Name:
            NameFull: Ceballos Lenza I
      – PersonEntity:
          Name:
            NameFull: Gutiérrez Calderón V
      – PersonEntity:
          Name:
            NameFull: Fuster Salvà J
      – PersonEntity:
          Name:
            NameFull: Pena Álvarez C
      – PersonEntity:
          Name:
            NameFull: Hernandez I
      – PersonEntity:
          Name:
            NameFull: Del Barco Morillo E
      – PersonEntity:
          Name:
            NameFull: Chaves Conde M
      – PersonEntity:
          Name:
            NameFull: Martínez Galán J
      – PersonEntity:
          Name:
            NameFull: Durán Sánchez M
      – PersonEntity:
          Name:
            NameFull: Quiroga V
      – PersonEntity:
          Name:
            NameFull: Ortega E
      – PersonEntity:
          Name:
            NameFull: Mesia R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2023 Aug 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1